Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical company announces 8% increase in net revenues for fourth quarter
April 14th, 2005
Noven Pharmaceuticals, Inc. (NOVN) announced financial results for the quarter and year ended December 31, 2004, and provided an update on its business and prospects. Noven's net revenues for the quarter ended December 31, 2004, were $12.7 million compared to $11.8 million for the quarter ended December 31, 2003. This 8% increase primarily reflected higher contract revenues, partially offset by lower unit sales of menopausal hormone therapy (HT) products. Research and development expense for the current quarter increased 44% to $2.2 million, primarily due to ongoing development projects and the addition of new personnel. Marketing, general and...
Source: Women's Health Weekly (2005-04-14)
|
